1100215-56-2

Upstream product

• 1100215-54-0 3-bromo-2-iodo-5-(trifluoromethyl)aniline 
• 1066-54-2 trimethylsilylacetylene 
• 54962-75-3 [3-bromo-5-(trifluoromethyl)phenyl]amine 

Downstream Products

• 1000342-93-7 4-bromo-6-(trifluoromethyl)-1H-indole 
• 1100215-58-4 3-bromo-2-ethynyl-5-(trifluoromethyl)aniline 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND

The present invention relates to a compound represented by the formula (I), which is useful as an agent for the prophylaxis or treatment of epilepsy, neurodegenerative disease and the like. In the formula (I), each symbol is as defined in the specification.

HETEROCYCLIC COMPOUND

The present invention provides a compound or a salt thereof useful for an agent for the prophylaxis or treatment of neurodegenerative disease and the like. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, or a salt thereof.

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.